|Event Name||Protein-Protein Interactions 2016
Monday, December 05, 2016
Tuesday, December 06, 2016
|Cost||GB£40 - GB£260
Virtually all vital cellular processes are controlled by protein-protein interactions (PPIs) including gene expression, proliferation, intracellular communication and apoptosis. Thus, understanding and manipulating PPIs represents a key objective in being able to understand healthy and disease biology. Achieving this goal will lead to probes of cell signalling pathways or, systems biology and next generation molecular therapeutics. However, to date, only a few PPIs have been the subject of a drug discovery initiative by the pharmaceutical industry.
Owing to the potential opportunities that being able to modulate PPIs would bring, the past decade has seen this field gain increasing scientific interest, and stimulated significant academic and industrial innovation. This meeting will address recent advances in the characterisation and identification of new PPI inhibitors. Topics will include: in silico assessment of PPI druggability, assay screening technologies for PPIs, structural biology approaches and fragment-based drug design. Speakers from industry and academia will describe strategies for addressing these challenges whilst showcasing the opportunity for creativity and innovation.
The event is aimed at all scientists (students, post-docs, academics, industrialists) engaged in PPI research, alongside those interested in finding out more about this topic. The meeting programme will appeal to chemists, biologists and the wider drug-discovery community. SCI Members can claim CPD points for attending this conference.